Case Study: An End-to-End Solution for Large Scale Adenovirus Manufacturing

With several recent FDA approvals and a strong drug pipeline, the gene therapy market is coming of age and providing new hope for patients. As demand for these new therapies increases, a robust and scalable manufacturing process is critical. In this webinar, we will present an end user case study which illustrates the challenges and solutions to scale both the upstream and downstream process steps required to manufacture adenoviruses.

 

Participants will learn how to:

 

• Accelerate time to market for adenovirus manufacturing

• Design the process for scalability

• Reduce downstream processing time from 3 - 4 days to 1 day

Speakers

Clive Glover, PhD

 

Senior Marketing Manager, Cell & Gene Therapy

Pall Biotech

Biography

Rachel Legmann, PhD

 

Senior Manager, Process Development Services

Pall Biotech

Case Study: An End-to-End Solution for Large Scale Adenovirus Manufacturing

Maximize Speed to Market Flexibility of Single-Use for Gene Therapy Manufacturing

더 Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
October 2021
Integrity Assurance for Single-Use Systems: An End-User’s Perspective

Biotech | Pall Corporation 웨비나 시리즈

Integrity Assurance for Single-Use Systems An End-User’s Perspective

 

What should you consider when building an integrity control strategy for your single-use systems (SUS)? How do you overcome application challenges?

 

Join leading industry experts Charlotte Masy of GSK and Patrick Evrard from Pall Corporation to gain insights and answers in this webinar from BioPharma Asia on integrity Assurance for Single-Use Systems, an End-User’s Perspective. They will present several case studies to show how integrity concerns can be practically addressed for cGMP manufacturing applications and the results observed a few years on. 

 

Attendees will learn about:

 

  • The latest regulatory requirements for integrity assurance of SUS
  • The different technologies available to control integrity of SUS
  • Key parameters that affect integrity measurements

 

Register now for this webinar from industry experts on October 6.

 

시청